Back to search
Autoimmune Diseases of the Nervous System
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Diseases of the Nervous System trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Diseases of the Nervous System trials you may qualify forThe primary goal of this project is providing evidence that a home-based combined cognitive-motor training program improves cognition in persons with multiple s…
This study will primarily evaluate the pharmacokinetics of satralizumab in pediatric patients aged 2-11 years with anti-aquaporin-4 (AQP4) antibody seropositive…
Individuals with MG (IwMG) experience shortness of breath that may be activity-related, occur at rest and even happen during sleep. Dyspnea is a complex, multid…
The main purpose of this study is to compare empasiprubart and IVIg for treating people with CIDP. This study consists of a Part A where participants will eithe…
The purpose of this study is to assess how well nipocalimab works when compared to efgartigimod in participants with generalized myasthenia gravis (a condition…
The main objective of this study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of a…
The brain possesses a system to get rid of unwanted substances, named Glymphatic System (GS). When this system is faulty, these accumulate, there is local infla…
The purpose of this study is to assess the long-term safety and tolerability of an additional 52 weeks of Zilucoplan treatment administered by subcutaneous inje…
The purpose of the study is to assess the long term safety and tolerability of additional 6-week treatment cycles with rozanolixizumab in pediatric participants…